MEDIQON Group AG (MDCKF) Ratios
MEDIQON Group AG Ratios
MDCKF's free cash flow for Q2 2026 was $10.72M. For the 2026 fiscal year, MDCKF's free cash flow was decreased by $-980.20K and operating cash flow was $11.70M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 21 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.93 | 18.34 | 2.26 | 13.54 | 11.85 |
| Quick Ratio | 4.66 | 17.37 | 2.12 | 12.57 | 11.04 |
| Cash Ratio | 3.50 | 13.00 | 1.75 | 9.12 | 8.96 |
| Solvency Ratio | 0.05 | 0.07 | 0.08 | 0.05 | 0.03 |
| Operating Cash Flow Ratio | 0.28 | 2.55 | 0.25 | 2.36 | 1.94 |
| Short-Term Operating Cash Flow Coverage | 0.81 | 0.73 | 0.33 | 0.75 | 0.97 |
| Net Current Asset Value | $ -201.28M | $ -46.22M | $ -34.14M | $ -45.26M | $ -42.36M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.37 | 0.21 | 0.31 | 0.50 | 0.37 |
| Debt-to-Equity Ratio | 1.11 | 0.33 | 0.55 | 1.21 | 0.66 |
| Debt-to-Capital Ratio | 0.53 | 0.25 | 0.35 | 0.55 | 0.40 |
| Long-Term Debt-to-Capital Ratio | 0.51 | 0.20 | 0.27 | 0.56 | 0.41 |
| Financial Leverage Ratio | 2.97 | 1.57 | 1.78 | 2.43 | 1.81 |
| Debt Service Coverage Ratio | -0.17 | 0.64 | 0.55 | 1.08 | 0.47 |
| Interest Coverage Ratio | -3.15 | -1.96 | 4.16 | -0.84 | 4.72 |
| Debt to Market Cap | 0.25 | 0.13 | 0.21 | 0.39 | 0.31 |
| Interest Debt Per Share | 11.06 | 3.44 | 4.05 | 4.90 | 4.03 |
| Net Debt to EBITDA | -58.96 | 0.92 | 1.15 | 5.67 | 7.43 |
| Profitability Margins | |||||
| Gross Profit Margin | -6.75% | 42.49% | 11.85% | 42.79% | 16.25% |
| EBIT Margin | -27.63% | -3.61% | 5.22% | 6.97% | -7.54% |
| EBITDA Margin | -1.32% | 14.77% | 22.81% | 25.00% | 11.45% |
| Operating Profit Margin | -27.63% | -9.54% | 24.83% | -6.59% | 29.50% |
| Pretax Profit Margin | -21.04% | -8.48% | -6.70% | -5.40% | -13.79% |
| Net Profit Margin | -16.40% | -10.36% | -5.77% | -7.91% | -13.99% |
| Continuous Operations Profit Margin | -22.24% | -11.07% | -9.03% | -7.57% | -15.70% |
| Net Income Per EBT | 77.92% | 122.18% | 86.18% | 146.44% | 101.45% |
| EBT Per EBIT | 76.15% | 88.87% | -26.98% | 82.04% | -46.74% |
| Return on Assets (ROA) | -4.46% | -3.24% | -1.82% | -2.19% | -3.48% |
| Return on Equity (ROE) | -13.24% | -5.10% | -3.24% | -5.32% | -6.28% |
| Return on Capital Employed (ROCE) | -7.87% | -3.02% | 9.01% | -1.84% | 7.46% |
| Return on Invested Capital (ROIC) | -7.74% | -2.90% | 8.10% | -1.78% | 7.21% |
| Return on Tangible Assets | -14.10% | -7.85% | -3.82% | -4.32% | -5.87% |
| Earnings Yield | -3.00% | -1.96% | -1.23% | -1.53% | -2.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.74 | 10.37 | 8.91 | 13.93 | 10.32 |
| Payables Turnover | 24.04 | 14.67 | 20.35 | 21.86 | 19.28 |
| Inventory Turnover | 23.05 | 14.64 | 15.74 | 20.40 | 14.80 |
| Fixed Asset Turnover | 17.54 | 10.38 | 10.00 | 20.37 | 12.13 |
| Asset Turnover | 0.27 | 0.31 | 0.32 | 0.28 | 0.25 |
| Working Capital Turnover Ratio | 1.83 | 1.93 | 2.07 | 2.74 | 1.79 |
| Cash Conversion Cycle | 54.80 | 35.26 | 46.21 | 27.40 | 41.09 |
| Days of Sales Outstanding | 54.15 | 35.20 | 40.95 | 26.20 | 35.36 |
| Days of Inventory Outstanding | 15.83 | 24.93 | 23.19 | 17.89 | 24.66 |
| Days of Payables Outstanding | 15.18 | 24.88 | 17.93 | 16.70 | 18.93 |
| Operating Cycle | 69.99 | 60.14 | 64.14 | 44.10 | 60.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.36 | 0.50 | 0.41 | 0.26 | 0.35 |
| Free Cash Flow Per Share | 0.29 | 0.30 | 0.21 | 0.10 | 0.23 |
| Dividend Paid and CapEx Coverage Ratio | 5.23 | 2.55 | 2.07 | 1.67 | 2.82 |
| Capital Expenditure Coverage Ratio | 5.23 | 2.55 | 2.07 | 1.67 | 2.82 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.16 | 0.11 | 0.06 | 0.09 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.10 | 0.10 | 0.10 | 0.14 |
| Free Cash Flow Yield | 0.71% | 1.19% | 1.15% | 0.78% | 1.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -33.47 | -50.91 | -81.32 | -65.51 | -37.95 |
| Price-to-Sales (P/S) Ratio | 5.47 | 5.28 | 4.69 | 5.18 | 5.31 |
| Price-to-Book (P/B) Ratio | 4.42 | 2.59 | 2.63 | 3.49 | 2.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 140.99 | 83.86 | 87.14 | 128.96 | 60.81 |
| Price-to-Operating Cash Flow Ratio | 114.05 | 50.92 | 45.08 | 51.66 | 39.23 |
| Price-to-Earnings Growth (PEG) Ratio | -0.23 | -0.40 | 2.01 | 0.78 | -0.14 |
| Enterprise Value Multiple | -472.08 | 36.63 | 21.72 | 26.40 | 53.80 |
| Enterprise Value | 1.13B | 598.93M | 350.63M | 189.10M | 259.14M |
| EV to EBITDA | -472.08 | 36.63 | 21.72 | 26.40 | 53.80 |
| EV to Sales | 6.25 | 5.41 | 4.95 | 6.60 | 6.16 |
| EV to Free Cash Flow | 161.11 | 86.02 | 92.00 | 164.23 | 70.56 |
| EV to Operating Cash Flow | 130.33 | 52.23 | 47.60 | 65.79 | 45.52 |
| Tangible Book Value Per Share | -5.92 | 0.76 | 0.39 | -0.84 | 1.44 |
| Shareholders’ Equity Per Share | 9.39 | 9.79 | 6.95 | 3.87 | 5.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.06 | -0.30 | -0.35 | -0.40 | -0.14 |
| Revenue Per Share | 7.58 | 4.81 | 3.90 | 2.60 | 2.62 |
| Net Income Per Share | -1.24 | -0.50 | -0.23 | -0.21 | -0.37 |
| Tax Burden | 0.78 | 1.22 | 0.86 | 1.46 | 1.01 |
| Interest Burden | 0.76 | 2.35 | -1.28 | -0.78 | 1.83 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.21 | 0.09 | 0.03 | 0.05 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.29 | -0.94 | -1.80 | -1.32 | -0.86 |
Currency in EUR
